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Abstract: Medical interventions for the treatment of spinal disc degeneration include total 
disc replacement and fusion devices. There are, however, concerns regarding the 
generation of wear particles by these devices, the majority of which are in the nanometre 
sized range with the potential to cause adverse biological effects in the surrounding tissues. 
The aims of this study were to develop an organ culture model of the porcine dura mater 
and to investigate the biological effects of CoCr nanoparticles in this model. A range of 
histological techniques were used to analyse the structure of the tissue in the organ culture. 
The biological effects of the CoCr wear particles and the subsequent structural  
changes were assessed using tissue viability assays, cytokine assays, histology, 
immunohistochemistry, and TEM imaging. The physiological structure of the dura mater 
remained unchanged during the seven days of in vitro culture. There was no significant 
loss of cell viability. After exposure of the organ culture to CoCr nanoparticles, there was 
significant loosening of the epithelial layer, as well as the underlying collagen matrix. 
TEM imaging confirmed these structural alterations. These structural alterations were 
attributed to the production of MMP-1, -3, -9, -13, and TIMP-1. ELISA analysis revealed 
that there was significant release of cytokines including IL-8, IL-6, TNF-Į, ECP and also 
the matrix protein, tenascin-C. This study suggested that CoCr nanoparticles did not cause 
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cytotoxicity in the dura mater but they caused significant alterations to its structural 
integrity that could lead to significant secondary effects due to nanoparticle penetration, 
such as inflammation to the local neural tissue. 
Keywords: total disc replacement; meninges; dura mater; nanoparticles; 
immunohistochemistry; cytokines; matrix metalloproteinases 
 
1. Introduction 
Lower back and neck pain are major health issues in Western countries [1]. A variety of pathologies 
can cause low and high back pain including degenerative disc disease. Degenerative disc disease 
results in abnormal motion leading to biomechanical instability and recurrent pain. When conservative 
treatment fails, patients and doctors consider other options, such as surgery. For many years, spinal 
fusion has been the gold standard of surgical treatment but the long term results have been poor and 
complications are common [2]. An alternative surgical procedure involves the replacement of the 
intervertebral disc with an artificial disc. Artificial discs include nuclear spacers (e.g., Fernstrom 
endoprosthesis, Ray prosthetic disc nucleus, Zimmer PEEK Ardis Interbody Inserter), total disc 
replacement devices (e.g., Charite, ProDisc, Kineflex, Cervicore, Maverick) and elastomeric devices 
(AcroFlex, Physio-L) [3,4]. All of these devices restore and maintain spinal segment motion while 
relieving pain. There are, however, concerns regarding total disc replacements in relation to the 
generation of wear debris that could lead to osteolysis, as well as other local and systemic effects [1]. 
A study of the AcroFlex device has highlighted the potential problem of wear particles leading to 
osteolysis [4]. Recently, the US Food and Drug Administration (FDA) issued a recall on the PEEK 
Ardis Interbody spacer due to the risk of fragmentation potentially leading to tears in the dura mater, 
leakage of cerebrospinal fluid and nerve injury [5]. Patients with metal-on-metal (MoM) total disc 
replacements have increased serum metal ion concentrations following surgery [6]. Several case 
reports have also revealed that MoM disc replacement devices can lead to the formation of 
granulomatous tissue with significant levels of metalosis that may occlude the surrounding arteries and 
veins and potentially cause spinal stenosis through infiltration of the spinal canal [7–9]. One case 
report documented signs of chronic inflammation in the epidural space during revision surgery of a 
cervical disc replacement. Histopathological analysis revealed a lymphocyte-dominated response that 
was similar to the soft tissue reaction reported in some patients with failed MoM hip prosthesis [10]. 
This is of particular concern for MoM devices, given the potential for toxicity of metal wear particles 
and the proximity to the spinal cord. 
Anatomically, the meninges enclose the spinal cord, and they consist of an outer fibroelastic layer, 
the dura mater, an intermediate arachnoid mater and the innermost pia mater [11]. The dura mater acts 
as a protective membrane for the spinal cord. It prevents the infiltration of foreign bodies harmful to 
the neural tissue and can protect the spinal cord from mechanical stresses such as stretching during 
movement and from changes in cerebrospinal fluid pressure [12–14]. 
The biological effects of wear particles generated in TDRs and their potential interactions with the 
dura mater (meninges) have the potential to pose a significant clinical problem, as evidenced by 
Nanomaterials 2014, 4 487 
 
reports on adverse soft tissue reactions to wear products in patients [10]. There are a limited number of 
studies that have investigated how particles interact with the dura mater and ultimately the central 
nervous system [15,16]. In our previous study [17], porcine fibroblasts and epithelial cells isolated 
from the dura mater were treated with clinically-relevant CoCr nanoparticles. The CoCr particles 
significantly reduced the viability of the dural epithelial cells in a dose-dependent manner and the cells 
secreted significant amounts of IL-8 at the highest particle doses [17]. Since the isolated cells grown in 
monolayer lack three-dimensional fibroblast/epithelial cell-cross-talk and cell/matrix interactions [18] 
it was important to extend our studies from a cellular level to a more physiological model of the intact 
tissue and to utilise multiple approaches to assess the overall biological response [19]. 
This study was therefore designed to test the hypothesis that CoCr nanoparticles cause significant 
biological effects on the dura mater. In order to test this hypothesis, an aseptic organ-culture model of 
the porcine dura mater was developed and exposed to different doses of 20–60 nm sized CoCr 
nanoparticles. The biological effects of the CoCr treatment and the structural changes to the tissue were 
assessed using tissue viability assays, assays of cytokine production, histology, immunohistochemistry, 
and TEM imaging of the treated vs. untreated tissue. 
2. Results and Discussion 
2.1. Histological Characterisation and Viability Assessment of Dura Mater in Organ Culture 
Porcine dura mater, freshly isolated from the meninges surrounding the spinal cord was processed 
for histology and sections were stained using H & E (Hematoxylin & Eosin) and visualised by light 
microscopy to determine its native characteristics. Native porcine dura mater was composed of an 
outer epithelial cell layer and an underlying dense collagen I and II matrix with interspersed fibroblast 
cells (Figure 1A,C,E,G). A more comprehensive study of the composition of the porcine dura mater 
has been reported in a previous study by Papageorgiou et al. [14]. The structural arrangement agreed 
with an ultrastructural study of the human meninges that showed that the dura mater was composed  
of an outermost loosely arranged fibroelastic layer, a central fibrous layer and an innermost  
cellular layer [11]. 
Porcine dura mater, freshly isolated from the meninges surrounding the spinal cord was maintained 
in organ culture for seven days and then subject to histological and immunohistochemical evaluation. 
After seven days of in vitro culture, the histological characteristics of the porcine dura mater remained 
unchanged (Figure 1B,D,F,H). There was no alteration in the structure of the dura mater. Porcine dura 
mater maintained in organ culture over a seven day period was also assessed for tissue viability using 
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay and there was no loss of 
viability (Figure 1K). There was a significant (p < 0.05) increase in MTT conversion after the first day 
of organ culture which was most probably due to the recovery of the tissue after the initial dissection 
process. MTT assay and immunohistochemical staining, have been used previously to assess tissue 
viability and tissue morphology in placental tissue explant cultures and buccal mucosa [20,21]. 
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Figure 1. Images of histological sections of the isolated porcine dura-mater tissue at Day 0 
(A) and after seven days in organ culture (B) stained with H&E. Immunohistochemical 
staining of the porcine dura mater with antibodies to fibronectin (C,D), collagen I (F,G), 
collagen II (I,J) at Day 0 and Day 7 respectively. Isotypes controls for fibronectin (E), 
collagen I (H) and collagen II (K) antibodies. Tissue viability over a period of 7 days in 
organ culture as determined by MTT assay (L). Results are presented as OD at 570 nm per 
mg of wet weight of tissue. Data is presented as the mean (n = 3) ± 95% confidence limits. 
Data were analysed by one-way analysis of variance and individual differences between 
group means determined by the T-method. * indicates significant difference (* p < 0.05). 
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Figure 2. (A) Representative image of cobalt-chrome nanoparticles that were generated 
using a pin-on-plate tribometer. Images were captured by FEGSEM; (B) Size distribution 
of cobalt-chrome nanoparticles. The size distribution of the cobalt-chrome nanoparticles 
was determined from SEM images taken from different locations on the filter membrane 
and analysed using Image Pro-Plus imaging software; (C) Effects of CoCr nanoparticles on 
the viability of dura-mater at 0 and 7 days of culture. Porcine dura mater tissue was 
cultured in the absence (control) and presence of CoCr nanoparticles at an estimated dose 
of 5 and 50 µm
3
 per epithelial cell and viability determined by the MTT assay. Data are 
expressed as the mean (n = 3) ± 95% confidence limits. The data were analysed by 
ANOVA which revealed no significant variation between control and CoCr-treated tissues 
at day 0 or day 7. Images of dura mater tissue exposed to cobalt-chrome nanoparticles at an 
estimated dosage of 0 (D), 5 (E) and 50 (F) µm
3
 per epithelial cell for a period of 7 days 
and stained with H&E. Tissues sections shown are orientated so that the outer epithelial 
layer is closest to the top of the section. 
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2.2. Cobalt-Chrome Alloy Nanoparticle Generation and Characterisation 
Nanometre-sized cobalt-chrome particles were generated using a pin-on-plate tribometer in distilled 
water and characterised using field emission gun scanning electron microscopy (FEGSEM) for size 
and shape. Six batches of particles were prepared and pooled. The particles were sonicated for 10 min 
prior to filtration to disperse agglomerates. The particles were round or oval in shape, with a few 
showing jagged edges (Figure 2A). Utilising Image Pro-Plus image analysis software, it was found 
that 68% of the particles were less than 100 nm in size, with 100 particles analysed from 6 randomly 
chosen regions of the filter. The highest percentile of nanoparticles fell within the 30–40 nm sized 
range (Figure 2B). Additional information regarding the properties of these CoCr nanoparticles, such 
as the sedimentation rate in tissue culture medium and metal ion release can be found in our  
previous publication [17]. 
2.3. Exposure of the Porcine Dura Mater to Cobalt-Chrome Nanoparticles 
Samples of porcine dura-mater tissue were incubated with CoCr nanoparticles at an estimated dose 
of 0, 5 and 50 µm
3
·cell
í1
 (0, 0.833 and 8.33 µg·mm
í3
 of tissue). Despite sonication of the particles 
immediately prior to tissue exposure, re-agglomeration of the particles was unavoidable [22,23]. 
Particle agglomeration would also likely occur in vivo. All exposures were repeated in triplicate at 
each time point and at each dose. The effect of nanoparticle exposure on tissue viability was 
determined immediately following exposure (day 0 of exposure) and after seven days of exposure 
(day 7) by MTT assay (Figure 2C). Optical densities for the MTT assays were corrected against tissue 
only controls without MTT. At day 0, exposure of the dura mater to 5 or 50 µm
3
·cell
í1
 of CoCr 
particles had no significant effect on tissue viability (p > 0.05) compared to the control tissue which 
had not been exposed to particles. After seven days of exposure to CoCr nanoparticles at 5 or 
50 µm
3
·cell
í1
, there was no significant difference in tissue viability compared to the control tissues. 
Both the day 0 and day 7 tissue samples across control and experimental groups showed consistent 
levels of viability (0.005–0.006 OD 570 nm·mg
í1
 tissue) and there were no significant differences 
between any groups (p > 0.05). 
The results for tissue viability following CoCr nanoparticle exposure were not entirely inconsistent with 
the results obtained in our previous study in which dural epithelial cells, but not dural fibroblasts isolated 
from the porcine dura mater showed a reduction in viability following exposure to CoCr nanoparticles 
at the same doses [17]. The differences between the results of the toxicity of CoCr nanoparticles obtained 
in organ culture and monolayer cell culture may be explained by differences in the behaviour of the 
epithelial cells in the two systems. With some toxic chemicals, the functional status of the cell (intrinsic 
cell characteristics) rather than the cell type determines the extent of its sensitivity to chemical toxicity. 
Such cellular characteristics may include membrane binding and permeability, intracellular synthetic 
pathways and adaptive and recovery mechanisms, which may differ in organ culture and monolayer 
cell culture [24]. Alternatively the results may simply have been due to the fibroblasts, being the 
predominant cell type in the dura, contributing the majority of MTT conversion in the assay of the 
tissue, with the assay not being sensitive enough to detect toxic effects of the particles on the epithelial 
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cells. Further studies using live/dead cell staining to determine any differential effects of the CoCr 
nanoparticles on the epithelial cells and fibroblasts in the organ culture would provide further insight. 
When the dura-mater tissue was cultured for seven days with 5 µm
3
 per epithelial cell of CoCr 
nanoparticles there were structural distortions to the epithelial layer compared to the control tissue 
observed in histological sections (Figure 2D,E). The epithelial layer detached from the outer edges of 
the tissue across an estimated 40% of the tissue sections. The remainder of the tissue appeared similar 
in structure to control tissues. Porcine dura-mater tissue incubated for seven days with 50 µm
3
·cell
í1
 of 
CoCr nanoparticles showed similar loosening of the collagen layer near the epithelium as well as the 
detachment of epithelial layer across the majority of the tissue section (Figure 2F). H & E staining of 
tissue sections also showed some loosening of the collagen layers immediately adjacent to the 
detached epithelial layer in small areas across the tissue in all replicates. 
Porcine dura-mater was visualised using transmission electron microscopy to determine the 
ultrastructural characteristics of the native tissue and to determine any possible structural defects 
following exposure to nanoparticles. In the control tissue after 7 days of organ culture, the epithelial 
cell-layer was observed surrounding the dura-mater that was mainly composed of a network of highly 
ordered collagen fibers (Figure 3A). Interspersed with the collagen bundles were regularly arranged 
fibroblasts (Figure 3B). This tight structure appeared to be disrupted when the dura mater was exposed 
to CoCr nanoparticles for 7 days. In the low dose organ culture (5 µm
3
·cell
í1
), the epithelial layer was 
disrupted on the apical side (Figure 3D), the fibroblasts appeared vacuolated (Figure 3E) and the basal 
layer of collagen appeared loosened (Figure 3F). Similar structural changes were observed in the 
tissues treated with the highest dose of CoCr particles (50 µm
3
·cell
í1
). In addition to disruption at the 
surface, the collagen fibres on the apical side were also disrupted (Figure 3G). The fibroblasts deep in 
the dura mater also showed signs of cellular degradation (Figure 3H), and in addition the basal layer of 
collagen also appeared loosened (Figure 3I). 
These preliminary histological and TEM observations suggested that there were structural 
alterations in the dura mater following exposure to CoCr nanoparticles for a period of seven days. In 
future studies it will be important to quantify this phenomenon further for example by: measurement of 
the transepithelial electrical resistance of the membrane, assessment of epithelial integrity through  
ZO-1 and E-cadherin staining, determination of total collagen and glycosaminoglycan content and 
biomechanical tests to determine any functional changes in the properties of the dura mater. In 
addition, the orientation of the collagen fibers could be quantified using atomic force microscopy [25] 
to determine any effects of CoCr nanoparticle exposure on the packing of the collagen fibers. 
  
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Figure 3. TEM images across the dura mater tissue that was exposed to CoCr nanoparticles 
for a period of seven days. (A–C) Images of the control dura mater from the epithelial 
region (A), inner collagen region (B) and the basal side of the dura mater close to 
arachnoid mater (C); (D–F) Images of the dura mater exposed to an estimated dose of 
5 µm
3
 of CoCr particles per epithelial cell, from the epithelial region (D), inner collagen 
region (E), and the basal side of the dura mater close to arachnoid mater (F); (G–I) Images 
of the dura mater exposed to an estimated dose of 50 µm
3
 of CoCr particles per epithelial 
cell, from the epithelial region (G), inner collagen region (H), and the basal side of the 
dura mater close to arachnoid mater (I). Single continuous black arrows indicate the dural 
epithelial cells. Single dotted black arrow indicated the dural fibroblast cells. Black circles 
indicated disruption of the collagen layer. 
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Figure 4. Pattern of cytokine and other mediator release during the exposure of porcine 
dura mater to CoCr nanoparticles for a period of 0–7 days. The dura mater organ culture 
was exposed to estimated doses of 0 (control), 5 and 50 µm
3
 of CoCr nanoparticles per 
epithelial cell. The factors that were investigated were IL-8 (A), IL-1ȕ (B), TNF-Į (C),  
IL-6 (D), LBT-4 (leukotriene B4) (E), IL-33 (F), ECP (eosinophil chemotactic protein, 
eotaxin, CCL-11) (G), and tenascin C (H). Data is expressed as the mean (n = 3) ±95% 
confidence limits. Data were analysed by one-way analysis of variance and individual 
differences between group means determined by the T-method. * indicates significantly 
difference between control and CoCr-treated tissue (* p < 0.05). 
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2.4. Proinflammatory Cytokine Response of the Dura Mater Exposed to Cobalt-Chrome Nanoparticles 
In order to determine if the CoCr nanoparticles had any effect on pro-inflammatory mediator 
release from the dura mater, the release of interleukin 8 (IL-8), tumour necrosis factor-Į (TNF-Į),  
IL-6, IL-1ȕ, and leukotriene B-4 (LTB-4) was measured daily in the organ culture conditioned 
medium for a period of seven days after the exposure of the organ culture to 5 and 50 µm
3
 CoCr 
nanoparticles per epithelial cell. There was significant release of IL-8 associated with both doses of 
CoCr nanoparticles compared to the control (Figure 4A). At the highest particle dose, the pattern of  
IL-8 release was continuous for the whole period of treatment (seven days). This IL-8 release was in 
agreement with the results of the previous study by Behl et al. [17], in which it was shown that dural 
fibroblasts and dural epithelial cells exposed to CoCr nanoparticles released significant amounts of  
IL-8. IL-8 release is a sign of a pro-inflammatory response of the tissue. IL-8 has a role in the 
recruitment and activation of neutrophils and T-lymphocytes [26,27]. In addition to its action as a 
chemokine, IL-8 induces neutrophils to release lysosomal enzymes and down-regulates collagen 
expression by human fibroblasts [26]. It might be hypothesized that in vivo, exposure of the dura mater 
to CoCr nanoparticles could stimulate the release of IL-8 resulting in the recruitment of neutrophils 
and release of lysosomal enzymes that would alter the structural integrity of the dura mater. 
The pattern of TNF-Į and IL-6 release was transient (Figure 4C,D). TNF-Į was released only during 
the first 24 h of exposure to nanoparticles in a dose dependent manner. According to Harada et al. [26] 
the production of IL-8 occurs in the presence of inflammatory stimuli such as IL-1 and TNF-Į. Hence, 
IL-8 release could have been initiated by the transient TNF-Į response of the tissue. IL-6 was also was 
significantly elevated in the first day of exposure to CoCr nanoparticle but only at the highest particle 
dose (50 µm
3
·cell
í1
). IL-6 release from the organ cultures exposed to CoCr nanoparticles was not 
consistent with the results from our previous study in which no significant IL-6 release was observed 
over a period of 4 days at a range of particle doses for both dural fibroblasts and dural epithelial 
cells [17]. Similar results were also observed in a study by Papageorgiou et al. [28], in which exposure 
of dermal fibroblasts to CoCr particles did not cause the release of significantly elevated levels of IL-6. 
The IL-6 release that was observed in the organ culture exposed to CoCr nanoparticles could have 
been the result of intercellular signaling between dural epithelial cells and dural fibroblasts. Such 
epithelial cell/fibroblast interactions have been documented in the lung airway wall [29] and involves 
cytokines such as IL-6 which can lead to [30] remodeling of the airway wall. Similarly, it can be 
hypothesized that the dural epithelial layer activates the underlying fibroblasts which in turns activate 
the epithelial layer further leading to an enhanced cytokine response. 
There was no IL-1ȕ or LTB-4 (leukotriene B4) released at any time or dose of exposure to the 
nanoparticles (Figure 4B,E). 
IL-33 is a member of the IL-1 cytokine family and is released by stressed epithelial cells and 
fibroblasts. Significant amounts of IL-33 were released between day 2 and day 5 at the highest CoCr 
nanoparticle treatment dose of 50 µm
3
·cell
í1
 (Figure 4F). This cytokine specifically modulates Th2-type 
proinflamatory signals after its release from necrotic cells that may promote eosinophilia [31].  
A similar phenomenon occurred with ECP release at the low particle treatment dose of 5 µm
3
·cell
í1
 
(Figure 4G). Nearly double the amount of ECP, relative to the control levels, was released from the 
treated dura mater between day 3 and day 6 of exposure to CoCr nanoparticles. Since ECP is 
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documented to promote eosinophilia [31], it might be hypothesized that CoCr nanoparticle exposure of 
the dura mater in vivo could stimulate the release of IL-33 and ECP that would in turn promote 
eosinophil recruitment to the site of CoCr nanoparticle exposure. 
Tenascin C in an extracellular matrix glycoprotein that has been reported to be expressed in 
response to tissue injury and infection [32,33]. Its expression is linked with cytokines associated with 
inflammation such as TNF-Į [34]. There was a significant release of tenascin C when the organ culture 
was exposed to the low particle dose (5 µm
3
·cell
í1
) after six days. However, for the high particle dose 
(50 µm
3
·cell
í1
) significantly lower amounts of tenascin C were released at all-time points, compared to 
the control values. It is possible that TNF-Į release in response to the low dose of CoCr nanoparticles 
caused the induction the tenascin expression. However, at the high dose of CoCr nanoparticles the drop 
of tenanscin C expression (even below the control tissue levels) could be attributed to the activation of 
MMP’s and the cleavage of tenascin-C. There is a feedback loop between induction of metalloproteases 
by tenascin-C and cleavage of tenascin-C by these enzymes [32]. Chiquet-Ehrisman et al. [35] 
suggested that the production of tenascin C in inflamed tissues belongs to a set of mechanisms required 
to control the spread of inflammation. 
2.5. MMP and TIMP-1 Expression in Dura Mater after Exposure to Cobalt-Chrome Nanoparticles 
Generally, MMP’s are not expressed in healthy tissues. However, MMP expression can be detected 
in inflamed tissues and/or in tissues under repair and remodelling. Metalloproteinases control the 
degradation of the extracellular matrix (as their name implies), they modulate chemokine activity of 
the inflamed region and they establish different chemokine gradients to modulate the influx of 
inflammatory cells [36]. The expression of MMPs was therefore investigated following exposure of 
the dural tissue in organ culture to CoCr nanoparticles. 
The tissue were investigated for the expression of MMP-1, -3, -9, and -13 since these are the MMPs 
implicated in collagen, and fibronectin degradation as well as disruption of the basement membrane 
and general remodelling of inflamed tissues [36,37]. The staining pattern of the CoCr-treated tissue is 
summarised in Table 1. 
Table 1. Expression pattern of different matrix metalloproteinases in dural epithelial and 
fibroblast cells as well as in the extracellular matrix exposed to CoCr wear nanoparticles of 
different doses. Control tissues showed no positive staining and are not included. (Intensity 
of staining was assessed as: ííí: no staining, +/í: very light staining, +: light staining, ++: 
strong staining, +++: very strong staining). 
 
CoCr Nanoparticle Treatment (µm
3
 per epithelial cell) 
5 µm
3
 50 µm
3
 
Type of 
MMP/TIMP  
Epithelial 
cells 
Fibroblasts  
Extracellular 
matrix 
Epithelial 
cells 
Fibroblasts  
Extracellular 
matrix 
MMP-1 ++ + ííí + + ííí 
MMP-3 ++ + + + +/í ííí 
MMP-9 +++ ++ ++ +++ ++ +++ 
MMP-13 + +/í +/í ++ ++ ++ 
TIMP-1 +++ +/í ííí + +/í ííí 
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Figure 5. Images of dura mater exposed for seven days to CoCr nanoparticles and stained 
for the presence of matrix metalloproteinases and TIMP-1 by immunhistochemistry. 
Images of section of control dura mater tissue (A,D,G,J,M), dura mater exposed to an 
estimated dose of 5 µm
3
 CoCr nanoparticles per epithelial cell (B,E,H,K,N) and dura 
mater exposed to an estimated dose of 50 µm
3
 CoCr nanoparticles per epithelial cell 
(C,F,I,L,O). The tissues were stained for MMP-1 (A–C), MMP-3 (D–F), MMP-9 (G–I), 
MMP-13 (J–L), TIMP-1 (M–O). 
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When the dura mater was exposed to both doses of nanoparticles MMP-1 was expressed in the 
cytoplasm of both dural epithelial and dural fibroblast cells (Figure 5B,C). The pattern of staining of 
MMP-3 was, however different. At the low particle dose (5 µm
3
·cell
í1
) MMP 3 was expressed by both 
cell types and was also present in the collagen region (Figure 5E). At the high particle dose (50 µm
3
·cell
í1
), 
there was only a limited amount of staining of the epithelial cells, but no staining was observed in 
dural fibroblasts or the collagen matrix (Figure 5F). According to a study by Chao et al. [38] increased 
levels of eotaxin not only induce MMP-3 gene expression but also promote MMP-3 protein secretion. 
It may be hypothesized that since eotaxin was released from the tissue during the six days of exposure 
to the low dose CoCr nanoparticles (Figure 4G), MMP-3 was produced and secreted from epithelial 
and fibroblast cells in response to eotaxin. 
MMP-9 was present in both dural epithelial and fibroblast cells as well as in the collagen region of 
the dural tissue that had been exposed to both doses of CoCr nanoparticles (Figure 5H,I). MMP-9 is 
reported to digest gelatin [37] and it may be hypothesized that it contributes to the structural alterations 
observed in CoCr-treated dura mater. 
Epithelial and fibroblast cells were stained positively for MMP-13 (Figure 5J,L), however, with the 
low dose treatment (5 µm
3
·cell
í1
) the collagen layer did not stain as intensively as with the high dose 
treatment (50 µm
3
·cell
í1
). This metalloproteinase, cleaves collagen I, II, and III [36] and may have 
contributed to the structural loosening that was observed in the dura mater treated with CoCr nanoparticles. 
MMP activities in tissues are regulated by specific inhibitors such as the tissue inhibitors of 
metalloproteinases (TIMPs). Four TIMP’s (TIMP-1, -2, -3, -4) have been identified in vertebrates and 
their expression is regulated in tissue remodelling [37]. TIMP-1 was chosen for investigation because 
it is a stromal factor that has a wide spectrum of functions in different tissues and can inhibit all the 
MMP’s investigated above [37,39]. The pattern of staining of TIMP-1 is shown in Figure 5M–O. At 
both particle treatment doses the dural epithelial cells were stained intensively; whereas the dural 
fibroblast cells and the collagen layer around them did not have any evidence of staining. Since the 
principal physiological role of TIMP-1 is to regulate the degradation of the basement membrane and 
the extracellular matrix by MMPs [40], the presence of TIMP-1 in the dural epithelial cells might 
indicate that this was upregulated in order to limit tissue degradation. It will be important to determine 
in future studies whether the observed MMP expression in the dura mater following exposure to CoCr 
nanoparticles correlates with enzyme activity using zymography [41]. 
3. Experimental Section 
3.1. Aseptic Isolation of the Dura Mater from Pigs 
Three pigs from the University of Leeds farm (Large White females, 65 kg) were humanely killed 
using a UK Home Office procedure and were brought to the dissection table within minutes of death. 
The skin on the back was swabbed with iodine solution and the vertebral column was aseptically 
dissected and transferred to the laboratory for further aseptic dissection. The vertebrae and spinal canal 
was dissected with bone cutters revealing the spinal cord with the surrounding meninges. The 
extracted spinal cord from each animal with the meninges still attached, was placed in an antimicrobial 
solution (200 mL) of Gentamicin (Sigma, Dorset, UK) 50 ng·mL
í1
 and Nystatin (Sigma, Dorset, UK) 
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100 U·mL
í1
 in medium 199 (Sigma, Dorset, UK) supplemented with foetal bovine serum (20% (v/v), 
Lonza, Slough, UK), L-glutamine (2 mM, Lonza, Slough, UK), sodium pyruvate (1.1 mg·mL
í1
, Sigma, 
Dorset, UK), heparin (10 U·mL
í1
), penicillin/streptomycin (50 U·mL
í1
 and 50 mg·mL
í1
 respectively, 
Lonza, Slough, UK) and endothelial growth factor (15 µg·mL
í1
, Sigma, Dorset, UK) for an hour at 
room temperature. 
3.2. Tissue Processing for Histology and H & E Staining 
Dura-mater tissue specimens were placed in zinc fixative solution (0.05% w/v calcium acetate, 
0.5% w/v zinc acetate, 0.5% w/v zinc chloride in 0.1 M Tris) for 24 h at room temperature and then cut 
into 1 cm wide blocks, which were processed in plastic cassettes (Histosette) into paraffin wax (Bios 
Europe Ltd., Skelmersdale, UK) using an automated tissue processor (Leica TP 1020, Leica 
Microsystems, Newcastle upon Tyne, UK). 
A microtome (RM2125RTR, Leica Microsystems, Newcastle upon Tyne, UK) was used to section 
the wax embedded blocks into 4–10 µm thick sections and the sections were then transferred onto 
Superfrost Plus slides (VWR International, Lutterworth, UK). The sections were air-dried for 30 min, 
dewaxed and rehydrated. Sections were stained using Mayer’s haematoxylin (Bios Europe Ltd., 
Skelmersdale, UK) and eosin (Bios Europe Ltd., Skelmersdale, UK) using a standard method, 
dehydrated and mounted using DPX mountant (Bios Europe Ltd., Skelmersdale, UK) Images were 
captured using an upright microscope (Olympus BX51, Southend-on-Sea, UK), a digital camera 
(Olympus XC50, Southend-on-Sea, UK) and Cell^B Image analysis software (Olympus, UK, 
Southend-on-Sea, UK). 
3.3. Immunohistochemistry 
Porcine dura mater tissue was characterised using immunohistochemistry with antibodies specific 
for collagen II (mouse anti-human polyclonal, COL-II, mouse IgG1; 1:50 dilution; Millipore Limited, 
Watford, UK), collagen I (mouse anti-human monoclonal, mouse IgG1k; 1:50 dilution; Millipore 
Limited, Watford, UK) and fibronectin (rabbit anti-human polyclonal, rabbit immunoglobulin fraction; 
1:400 dilution, DakoCytomation, Cambridgeshire, UK). 
Sections were subject to antigen retrieval using proteinase K (DAKO, S3020) for 20 min  
prior to immunohistochemical staining using the Ultra vision kit (Envision, Birmingham, UK) and 
counterstaining with haematoxylin as described previously [14] Images were captured as above. 
3.4. CoCr Nanoparticle Production and Characterisation 
Particles were generated in a six station pin-on-plate tribometer (manufactured in the School of 
Mechanical Engineering, Leeds University, UK) with water as the lubricant under a load of 80 N for 
40 h as described previously [14,17]. The pins and plates were manufactured from medical grade 
wrought high carbon (<0.2%) CoCr alloy ASTM F1537 with smooth counterfaces (Ra: 0.01–0.02 µm). 
Wear particles were sterilised at 180 °C for 4 h and their mass determined by gravimetric analysis. The 
particles were suspended at 1 mg·mL
í1
 in sterile water. A sample of the particle suspension was 
captured on a 0.015 µm polycarbonate filter membrane (Millipore Limited, Watford, UK) and 
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characterized using field emission gun scanning electron microscopy (FEGSEM; FEI, Eindhoven, The 
Netherlands) and Image Pro-Plus
®
 image analysis software (Media Cybernetics, Rockville, MD, 
USA). A total of 100 particles per image were analysed from 3 images. 
3.5. Maintenance and Treatment of Dura Mater with CoCr Nanoparticles 
The dissected spinal cord with the meninges was aseptically dissected into 12 mm
2
 segments and 
the dura mater was removed and placed on top of sterile Transwell
®
 permeable supports/inserts 
(diameter of pores: 3 µm; Corning, Flintshire, UK). The orientation of the dura mater was arranged 
with the epithelial layer was facing upwards. The inserts with the dura mater were then placed in a  
6-well plate and the wells filled with m199 medium (Sigma, Dorset, UK) supplemented with foetal 
bovine serum (20% (v/v), Lonza, Slough, UK), L-glutamine (2 mM, Lonza, Slough, UK), sodium 
pyruvate (1.1 mg·mL
í1
, Sigma, Dorset, UK), heparin (10 U·mL
í1
), penicillin/streptomycin (50 U·mL
í1
 
and 50 mg·mL
í1
, Lonza, Slough, UK) and endothelial growth factor (15 µg·mL
í1
, Sigma, Dorset, UK). 
The porous nature of the insert ensured that nutrients passed to the tissue. The medium was replaced 
daily and the conditioned medium stored frozen at í20 °C for mediator assay. The dura mater was 
hydrated from the epithelial side with a few drops of medium on a daily basis. 
The stock suspension of the CoCr nanoparticles (1 mg·mL
í1
) was diluted 100 and 1000 times in 
complete medium m199 to achieve particle suspensions of 100 and 10 µg·mL
í1
 (at an estimated dose of 
50 µm
3
 and 5 µm
3
 per cell and replicated three times). The particles were sonicated in an ultrasonicating 
bath (Grant Instruments Limited, Cambridgeshire, UK) for 10 min immediately before use. The dura 
mater tissue segments were then treated on the epithelial surface with 1 mL of the appropriate CoCr 
particle suspensions (100 and 10 µg per tissue section). The particles were added to the epithelial side 
of the dura mater to mimic the way that the particles would come into contact with meninges in vivo. A 
control sample with 1 mL medium only was also included (negative control). For each treatment three 
replicate samples were prepared. The samples were incubated for 0 and 7 days in 5% (v/v) CO2 in air 
at 37 °C. 
3.6. Determination of the Effects of Cobalt-Chromium Nanoparticles on Tissue Viability 
The effects of CoCr nanoparticles on the viability of the dura mater were evaluated using the  
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay according to a standard 
procedure [42]). The dura mater was dissected aseptically and tissue sections of different weights were 
incubated with agitation in 600 µL of MTT solution (2.5 mg·mL
í1
 in PBS) at 37 °C for 4 h. Following 
incubation, the samples were centrifuged at 300 g for 5 min and the supernatant discarded. DMSO 
(1 mL) was added and the samples were incubated at 37 °C with rotation overnight (~16 h) in the dark. 
The samples were centrifuged at 300 g for 5 min and 100 µL aliquots of each sample were transferred 
to individual wells of a 96-well plate. The optical densities were measured using a Multiskan Spectrum 
plate reader at 570 nm with a reference filter at 630 nm (Thermo Labsystems, Cheshire, UK). The 
optical density of each sample was normalised to the weight of the tissue and the data are presented as 
OD (570–630) mg
í1
 of tissue. 
  
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3.7. Determination of the Effects of Cobalt-Chromium Nanoparticles on Cytokine and Other  
Mediator Secretion 
The levels of TNF-Į, IL-1ȕ, IL-6, and IL-8 present in the conditioned medium collected every  
24 h were evaluated using commercial sandwich enzyme-linked immunosorbent assay (ELISA) kits 
(R & D systems, Abington, UK) following the manufacturer’s instructions. The levels of leukotriene 
B4 (LTB4) were evaluated using an LTB4 immunoassay kit (R & D systems, Abington, UK) 
following the manufacturer’s instructions. 
The levels of IL-33 (a member of IL-1 superfamily) and eotaxin or CCL-11 eosinophil chemotactic 
protein (ECP) produced by the cells were measured with an ELISA kit (Blue Gene, Shanghai, China) 
according to the manufacturer’s instructions. Tenascin C was measured with an ELISA kit 
(MyBioSource Inc., San Diego, CA, USA) according to manufacturer’s instructions. 
3.8. Immunohistochemical Staining of the Tissue for MMPs and TIMP-1 Following Treatment with 
CoCr Nanoparticles 
Porcine dura mater tissue (treated with CoCr nanoparticles and untreated controls) was embedded 
in OTC matrix (R.A Lamb, East Sussex, UK). Sections were cut using a cryotome (Leica, Milton 
Keynes, UK) and stored at í20 °C until required. Cryosections were stained using antibodies to tissue 
inhibitor of metalloproteinase’s 1 (TIMP-1; rabbit anti-human polyclonal, P01033, IgG; 1:133 
dilution; Abbiotec, San Diego, CA, USA), matrix metalloproteinase 1 (MMP-1; rabbit anti-human 
polyclonal, IgG; 1:133 dilution; BioSS, Woburn, MA, USA), MMP-3 (mouse anti-human monoclonal; 
55-2A4; IgG1/k; 1:250 dilution; Millipore, Billerica, MA, USA), MMP-9 (mouse anti-human 
monoclonal; 4A3; IgG1; 1:25 dilution; AbD Serotec, Kidlington, UK) and MMP-13 (rabbit  
anti-human polyclonal; IgG1; 1:133 dilution; Abbiotec, San Diego, CA, USA). Mouse IgG2 
(1:30 dilution; DakoCytomation, Cambridgeshire, UK) and rabbit anti-human immunoglobulin factor 
(1:750 dilution; DakoCytomation, Cambridgeshire, UK) were used as isotype controls. 
Cryosections were stained, visualised and images captured as described above (Section 3.3). 
3.9. Transmission Electron Microscopy (TEM) of the Treated vs. Untreated Tissue 
Dura mater samples that had and had not been treated with CoCr nanoparticles were fixed with 
2.5% (v/v) glutaraldehyde in 0.1 M phosphate buffer for 2.5 h. The tissue was then washed twice for 
30 min with 0.1 M phosphate buffer followed by fixation with 0.1% (w/v) osmium tetroxide overnight. 
The tissue was then washed with 0.1 M phosphate buffer and incubated in an ascending alcohol series 
of 20%, 40%, 60%, 80%, and twice in 100% for 20 min for each wash. Following this, the tissue was 
washed twice with propylene oxide for 20 min and placed in a 50%–50% Araldite-propylene oxide 
mixture overnight, followed by a 75%–25% Araldite-propylene oxide for 7 h. Finally the tissue was 
placed in neat fresh Araldite for 8 h and transferred to embedding moulds to polymerase overnight  
at 60 °C. 
Sections (70 nm) were cut using a glass blade in an Ultracut TEM microtome and picked up on 
metal grids. The grids were placed on drops of 8% (v/v) uranyl acetate with the section side facing 
down for 2 h at room temperature. The grids were then washed with distilled water and placed on 
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drops of lead citrate in 1 M NaOH for 30 min at room temperature. The grids were washed with 0.1 M 
NaOH solution and then distilled water. 
Images were captured from the grids using a CM10 TEM microscope (Philips, Surrey, UK). The 
images were taken using a two second exposure time at any given magnification. 
3.10. Statistical Analysis 
Data are presented as the mean and 95% confidence limits. Data were analysed using one way 
analysis of variance followed by calculation of the minimum significant difference between group 
means using the student T-test method at p = 0.05. 
4. Conclusions 
This study, for the first time established a model organ culture of the porcine dura mater. The model 
was used to study the effects of nanosized CoCr wear particles. Two physiological doses of CoCr 
nanoparticles (5 and 50 µm
3
 per epithelial cell) were used to treat the dura mater for a period of seven 
days with no significant effects on cell viability. However, histological analyses as well as TEM 
imaging of the CoCr treated tissues revealed dose dependent loosening of the dural epithelial layer as 
well as the underlying connective tissue layer compared to untreated control tissue. 
These structural alterations coincided with the release of significant levels of IL-8, IL-6, TNF-Į, as 
well as ECP and tenascin-C. The pattern of release of these mediators over the seven-day period  
of treatment with the CoCr nanoparticles, suggested that the CoCr particles stimulated a  
pro-inflammatory response in the tissue. This inflammatory response coincided with the expression of 
matrix metalloproteinases MMP-1, -3, -9, and -13 which suggested that a catabolic, matrix degrading 
response occurred in the tissue. MMP expression supported the histological changes observed in the 
CoCr-treated tissue. A limitation of this study was that it was based on current understanding of CoCr 
nanoparticle wear particle generation by MoM articulations in vitro. There is a lack of current 
knowledge regarding whether the CoCr wear particles released by MoM TDRs in vivo is of a  
similar nature. 
These findings, however, give an initial insight into how CoCr nanoparticles generated in MoM 
TDR might interact with the dura mater. The results indicated that the particles have the potential to 
adversely affect the barrier/protective function of the dura mater and also the meninges. Further 
research is required to assess the biological consequences of the penetration of CoCr nanoparticles 
through the dura mater, particularly on the function of the dura mater in terms of barrier function and 
mechanical integrity. 
In addition, it is important to assess if the wear debris from other materials used in the spinal 
implants e.g., polyethylene, polyether ether ketone (PEEK), stainless steel, titanium, have the ability to 
cause similar structural and biological changes in the dura mater. 
  
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